Researchers found that altering key enzymes involved in redox balance could disrupt the metabolism of Myc-driven lymphomas, which offers a potential new strategy to treat aggressive cancers.

Vice president and market executive at Highmark Health. Highmark Health is a national health and wellness organization serving nearly 50 million Americans.

Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV care and research in the United States, according to Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C.

A survey by PSG has found that the pressure to control drug costs is leading some payers to look into unbundling pharmacy benefits as a way for better control.

Switching to Humira biosimilars saved Navitus clients more than $315 million in upfront costs in 2024 and resulted in a 60% reduction in net costs per claim.

Gen Z was the age group most likely to spend the money on GLP-1 agonists; still, only 27% would.

The Arthritis Foundation is funding a study to help predict the onset and progression of interstitial lung disease in rheumatoid arthritis patients

CEO at Serve You Rx. Serve You Rx is a midmarket pharmacy benefit manager (PBM) for self-funded employers.

Senior director of clinical programs at Capital Rx Capital Rx is an enterprise health technology company and public benefit Capital Rx is an enterprise health technology company and public benefit corporationbthat provides various healthcare benefit administration solutions for commercial, Medicare and Medicaid plans.

Dual eligibility was a proxy for high social risk in a retrospective study that compared outcomes in that group with individuals with other types of health insurance coverage.

AI apps that can detect skin cancer can be manipulated and potentially miss cases of melanoma, a serious skin cancer.

Here’s what you missed this week on Managed Healthcare Executive.

In a new Wolters Kluwer report, it was revealed that 80% of respondents cited “optimizing workflows” as a top organizational goal, but only 63% felt prepared to use GenAI to achieve that.

Vice president of postacute care solutions at OneHome. OneHome is a postacute services business for Medicare Advantage members offering engaged, at-risk network oversight for home healthcare, skilled nursing facilities, durable medical equipment and infusion services.

The United States has the highest maternal mortality rate of any high-income country, a crisis perpetuated by the lack of federal funding of pregnancy research, according to a review published in JAMA Health Forum.

Ernst & Young study shows 85% of participating organization leaders are seeing better patient outcomes, and nearly 75% report financial benefits when focusing on outcome-driven strategies.

Director of clinical effectiveness and operations at Prime Therapeutics LLC. Prime Therapeutics is a pharmacy benefits manager owned by 19 Blue Cross and Blue Shield plans.

The pharmacy benefit manager (PBM) industry is under pressure to shift to models that avoid conflicts of interest and misaligned incentives.

Current treatment options have improved survival rates but have not provided a cure. Eventually, initial therapies stop working, and many patients relapse.

As researchers continue to explore more effective solutions, combining platelet-rich plasma (PRP) with fractional laser therapy has gained increasing attention.

While heritable human genome editing is banned in the United States, across Europe and much of the world, the technology raises concerns about potential misuse.

Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, cybersecurity was not ranked as a top business challenge, according to the results of Omega Systems’ 2025 Healthcare IT Landscape Report.

Chief of pharmacy at CareAllies. CareAllies is a population health company that supports physician practices and health plans.